Pioglitazone, extract of compound Danshen dripping pill, and quercetin ameliorate diabetic nephropathy in diabetic rats

Journal of Endocrinological Investigation

Volumn 36, Issue 6, 2013, Pages 422-427

  Chen, P ^a   Chen, J ^b   Zheng, Q ^a   Chen, W ^a   Wang, Y ^a   Xu, X ^a  

^a FUZHOU GENERAL HOSPITAL   (China)

^b Armed Police Corps Hospital in Fujian   (China)

Author keywords

Danshen dripping pill; Diabetes mellitus; NF B p65; Quercetin; Ubiquitin

Indexed keywords

PIOGLITAZONE; QUERCETIN; TRANSCRIPTION FACTOR RELA; UBIQUITIN;

ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GLOMERULUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY HYPERTROPHY; KIDNEY MASS; KIDNEY TUBULE; MALE; NONHUMAN; PATHOGENESIS; PILL; PROTEIN EXPRESSION; RAT; SALVIA MILTIORRHIZA; SERUM; TREATMENT DURATION; URINALYSIS;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUGS, CHINESE HERBAL; HYPOGLYCEMIC AGENTS; KIDNEY; MALE; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; TABLETS; THIAZOLIDINEDIONES;

EID: 84881443273     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8763     Document Type: Article

References (33)

1. Masoudi FA, Inzucchi SE. Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy. Am J Cardiol 2007, 99: 113B-32B.
2. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009, 301: 2129-40.
3. Marcovecchio ML, Lucantoni M, Chiarelli F. Role of chronic and acute hyperglycemia in the development of diabetes complications. Diabetes Technol Ther 2011, 13: 389-94.
4. Najafian B, Alpers CE, Fogo AB. Pathology of human diabetic nephropathy. Contrib Nephrol 2011, 170: 36-47.
5. Navarro-González JF, Mora-Fernández C, Muros de Fuentes M, García-Pérez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 2011, 7: 327-40.
6. Hanif K, Bid HK, Konwar R. Reinventing the ACE inhibitors: some old and new implications of ACE inhibition. Hypertens Res 2010, 33: 11-21.
7. Shah P, Mudaliar S. Pioglitazone: side effect and safety profile. Expert Opin Drug Saf 2010, 9: 347-54.
8. Stewart LK, Soileau JL, Ribnicky D, et al. Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet. Metabolism 2008, 57: S39-46.
9. Xie W, Du L. Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes Metab 2011, 13: 289-301.
10. Tao W, Deqin Z, Yuhong L, et al. Regulation effects on abnormal glucose and lipid metabolism of TZQ-F, a new kind of Traditional Chinese Medicine. J Ethnopharmacol 2010, 128: 575-82.
11. Liu CL, Xie LX, Li M, Durairajan SS, Goto S, Huang JD. Salvianolic acid B inhibits hydrogen peroxide-induced endothelial cell apoptosis through regulating PI3K/Akt signaling. PLoS One 2007, 2: e1321.
12. Zhao Y, Krishnamurthy B, Mollah ZU, Kay TW, Thomas HE. NF-κB in type 1 diabetes. Inflamm Allergy Drug Targets 2011, 10: 208-17.
13. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54: 1615-25.
14. Grune T, Reinheckel T, Davies KJ. Degradation of oxidized proteins in mammalian cells. FASEB J 1997, 11: 526-34.
15. Donaldson KM, Li W, Ching KA, Batalov S, Tsai CC, Joazeiro CA. Ubiquitin mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc Natl Acad Sci USA 2003, 100: 8892-7.
16. Goellner GM, Rechsteiner M. Are Huntington's and polyglutamine based ataxias proteasome storage diseases? Int J Biochem Cell Biol 2003, 35: 562-71.
17. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001, 292: 1552-5.
18. Marfella R, D' Amico M, Di Filippo C, et al. The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes. Cardiovasc Diabetol 2007, 6: 35.
19. Susztak K, Raff AC, Schiffer M, Böttinger EP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006, 55: 225-33.
20. Kumar D, Zimpelmann J, Robertson S, Burns KD. Tubular and interstitial cell in the steptozotocin diabetic rat kidney. Nephron Exp Nephrol 2004, 96: 77-88.
21. Derosa G. Efficacy and tolerability of pioglitazone in patients with type 2 diabetes mellitus: comparison with other oral antihyperglycaemic agents. Drugs 2010, 70: 1945-61.
22. Moraes LA, Piqueras L, Bishop D. Peroxisome proliferator activated receptors and inflammation. Pharmacol Ther 2005, 14: 2-4.
23. Marfella R, D'Amico M, Esposito K, et al. The Ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques. Diabetes 2006, 55: 622-32.
24. Tian JY, Chen JZ, Gu Y, Xi SF. Effect of fufang danshen diwan on blood lipid level and carotid atherosclerosis plaque in rabbits. Chin J Clin Rehabil 2004, 22: 437.
25. Xu JL, Wang XM, Wang DX. The protection of composite salviae dropping pills against HUVECs injury induced by H2O2. Chin J Pathophysiol 2006, 22: 929.
26. Chen P, Xu XJ, Shi DH. The influence of compound Danshen dripping pill on insulin resistance in rats. Chin J Integr Med Cardio/Cerebrovasc Dis 2008, 6: 33-6.
27. Xu P, Xu XJ, Shi DH. Anti-proliferative effects of compound Danshen dripping pill on rabbit aortic smooth muscle cells during the insulin resistance state. Chin J Integr Tradit West Med Intens Crit Care 2007, 14: 313-6.
28. Moon SK, Cho GO, Jung SY, et al. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun 2003, 301: 1069-78.
29. Vessal M, Hemmati M, Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol Toxicol Pharmacol 2003, 135: 357-64.
30. Coskun O, Kanter M, Korkmaz A, Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozocin induced oxidative stress and β-cells damage in rat pancreas. Pharmacol Res 2005, 51: 117-23.
31. Kamada C, da Silva EL, Ohnishi-Kameyama M, Moon JH, Terao J. Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesteol-fed rabbit. Free Radic Res 2005, 39: 185-94.
32. Xu XJ, Zhang LQ, Wang QB, Feng XG, Zheng ZY, Chen P. Protective effect of quercetin on kidneys in diabetic rats. Chin J Endocrinol Metab 2001, 17: 316-9.
33. Xu XJ, Wu YS, Feng XG, et al. Effects of quercetin on TGF-β1 in diabetic rat kidney. Chin J Diabetes 2001, 9: 44-8.